DEFA14A ·Filed Apr 24, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a standard proxy filing with no material changes. Monitor the company's next earnings release for any significant business developments.
SRPT drugs
SRPT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60Entry
$20.89
T+0 close · Apr 24, 2026 · via day close
Latest settled
−24.25%
T+60 · $15.82
Vs SPY
−28.76%
α at T+60
Horizons
All settled
through T+60
- T+0 · Apr 27 $20.89entry
- T+1 · 7mo ago +0.43%α +0.92% · $20.98
- T+5 · 7mo ago +4.93%α +4.53% · $21.92
- T+20 · 6mo ago −20.18%α −25.14% · $16.67
- T+60 · 4mo ago −24.25%α −28.76% · $15.82
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Sarepta Therapeutics filed a definitive proxy statement (DEFA14A) for its annual shareholder meeting, which includes routine information about director elections, executive compensation, and other corporate governance matters. The filing is standard and does not contain any material changes or unexpected events.
Key Financial Metrics
Vote
director election
Key Facts
- Filing is a routine DEFA14A proxy statement for Sarepta Therapeutics
- Contains standard information about director elections, executive compensation, and corporate governance
- No material changes, unexpected events, or activist campaign mentioned
- Filing is required for annual shareholder meeting
Financial Impact
No immediate financial impact
none
Risk Factors
- None identified from this filing
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
39% bullish (33 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-177258 |
| Document: 0001193125-26-177258-index-headers.html | 0001193125-26-177258 |
| Document: 0001193125-26-177258-index.html | 0001193125-26-177258 |
| Document: 0001193125-26-177258.txt | 0001193125-26-177258 |
Track record
9 reports on SRPT
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $16.07 Now $15.13 −5.85% settles Dec 14
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $16.42 Now $15.13 −7.86% settles Dec 9
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $17.82 Now $15.13 −15.10% settles Dec 7
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $18.54 Now $15.13 −18.39% settles Dec 2
- Jul 27, 202616w ago 8-K Neutral 3/10 Entry $15.89 to $18.13 Now $15.13 −4.78% ▲ +14.10% +10.80% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $15.00 to $20.52 Now $15.13 +0.87% ▲ +36.80% +34.91% vs SPY
- Jun 4, 202623w ago 8-K Neutral 3/10 Entry $15.75 to $19.18 Now $15.13 −3.94% ▲ +21.78% +19.92% vs SPY
- Apr 24, 202629w ago DEFA14A Neutral 3/10 Viewing Entry $20.89 to $16.67 Now $15.13 −27.56% ▼ −20.18% −25.14% vs SPY
- Feb 25, 202637w ago 8-K Mixed 7/10 Entry $17.45 to $21.68 Now $15.13 −13.30% ▲ +24.24% +30.65% vs SPY
Showing 9 of 9
US Market Status
Market Closed · Opens in 9h 15m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers